The journal Circulation said this week that the all-cause mortality rates in a study comparing a paclitaxel stent and percutaneous transluminal angioplasty in people with peripheral artery disease were “inadvertently reversed” by the authors. In the first version of the paper, originally published in 2016, researchers reported that the 5-year all-cause mortality rate for people treated with Cook […]
Medtronic
Medtronic launches DBS for medically-refractory epilepsy in the U.S.
Medtronic (NYSE:MDT) said today that it launched its Deep Brain Stimulation system intended for medically-refractory epilepsy in the U.S. The Fridley, Minn.-based company said that the first patient was implanted with the system at Atlanta’s Emory University. “At Medtronic, we have a long-standing commitment to helping patients with medically refractory epilepsy through DBS, and we continue […]
Medtronic looks to retire up to $5b in debt
Medtronic (NYSE:MDT) today announced a cash tender offer for up to $5 billion in outstanding debt, according to recently posted SEC filing. In the offer, which is being made through Medtronic Inc. and its Covidien International Finance subsidiary, the Fridley, Minn.-based company hopes to retire $2.5 billion in 2.5% senior notes due 2020 and $600 million […]
Medtronic risk prediction tool could help prevent opioid deaths: Here’s how
Medtronic officials continue to hone their arguments for how the company’s capnography and oximetry systems could reduce potentially deadly opioid-induced respiratory compromise. The medical device giant on Feb. 17 announced preliminary results of its Prodigy study, in which the company’s Microstream and Nellcor monitoring technology provided continuous capnography and oximetry for 1,496 patients across 16 sites in the […]
Medtronic shares rise on FY2019 Q3 earnings beat
Shares in Medtronic (NYSE:MDT) are up today after the medical device giant posted third quarter fiscal year 2019 earnings that beat expectations on Wall Street. The Fridley, Minn.-based company posted profits of approximately $1.27 billion, or 94¢ per share, on sales of approximately $7.55 billion for the three months ended January 25, seeing a swing from […]
Medtronic: Patient deaths left out of paclitaxel-coated balloon analysis
Medtronic (NYSE:MDT) said last week that it inadvertently omitted an undisclosed number of patient deaths from recent studies of its paclitaxel-coated balloons. The company noted that the mistake ultimately does not affect the conclusion that there was no statistically significant difference in all-cause mortality between its In.Pact Admiral drug-coated balloon and plain balloon angioplasty at five years. Get […]
Medtronic wins FDA’s breakthrough status for closed-loop insulin system
Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Get the full story at our sister site, Drug Delivery Business News.
Medtronic inks 5-year value-based healthcare deal with S.C. hospital
Medtronic (NYSE:MDT) said today that it inked a five-year value-based healthcare partnership deal with the Medical University of South Carolina, looking to improve health outcomes, patient care experiences and reduce costs. Fridley, Minn.-based Medtronic said the partnership will initially focus on addressing chronic disease and acute conditions prevalent in the region. An initial program involves standardizing […]
3M names CEO Roman as board chair | Personnel Moves – February 7, 2019
3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]
FDA expands indications for Medtronic’s Pipeline Flex embolization device
Medtronic (NYSE:MDT) said today it won expanded FDA approval for its Pipeline Flex embolization device. The device is now indicated for patients with small or medium, wide-necked brain aneurysms in the territory from the petrous to the terminus of the internal carotid artery, the Fridley, Minn.-based company said. The Pipeline Flex was previously cleared for the […]
Medtronic touts study data for thoracic aortic stent
Medtronic (NYSE:MDT) said that its thoracic stent graft for the treatment of a potentially deadly blunt-force chest injury performed well five years after implantation, according to a new study. The Rescue study of the long-term durability, safety, and efficacy of the Medtronic’s Valiant Captivia thoracic stent graft system for blunt thoracic aortic injury (BTAI) was presented […]